Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis

The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's Navitor™ TAVI system for aortic stenosis, a common and life-threatening heart valve disease The investigational system is designed to offer best-in-class heart blood flow, ease of use and precision Approximately 9% of older Americans have aortic stenosis1ABBOTT PARK, Ill., Nov. 25, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the first patient procedures with its investigational transcatheter aorti ...